Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 99

    1.

    National Institutes of Health Consensus Development Conference Statement: management of hepatitis B.

    Sorrell MF, Belongia EA, Costa J, Gareen IF, Grem JL, Inadomi JM, Kern ER, McHugh JA, Petersen GM, Rein MF, Strader DB, Trotter HT.

    Ann Intern Med. 2009 Jan 20;150(2):104-10. Epub 2009 Jan 5. No abstract available. PMID: 19124811 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Antiviral therapy for adults with chronic hepatitis B: a systematic review for a National Institutes of Health Consensus Development Conference.

    Shamliyan TA, MacDonald R, Shaukat A, Taylor BC, Yuan JM, Johnson JR, Tacklind J, Rutks I, Kane RL, Wilt TJ.

    Ann Intern Med. 2009 Jan 20;150(2):111-24. Epub 2009 Jan 5. Review.PMID: 19124812 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    NIH Consensus Statement on Management of Hepatitis C: 2002.

    [No authors listed]

    NIH Consens State Sci Statements. 2002 Jun 10-12;19(3):1-46. Review.PMID: 14768714 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Hepatocellular carcinoma is associated with an increased risk of hepatitis B virus recurrence after liver transplantation.

    Faria LC, Gigou M, Roque-Afonso AM, Sebagh M, Roche B, Fallot G, Ferrari TC, Guettier C, Dussaix E, Castaing D, Brechot C, Samuel D.

    Gastroenterology. 2008 Jun;134(7):1890-9; quiz 2155. Epub 2008 Mar 4.PMID: 18424269 [PubMed - indexed for MEDLINE]Related articles

    5.

    Natural history of hepatitis B virus infection: an update for clinicians.

    Pungpapong S, Kim WR, Poterucha JJ.

    Mayo Clin Proc. 2007 Aug;82(8):967-75. Review.PMID: 17673066 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    A mathematical model to estimate global hepatitis B disease burden and vaccination impact.

    Goldstein ST, Zhou F, Hadler SC, Bell BP, Mast EE, Margolis HS.

    Int J Epidemiol. 2005 Dec;34(6):1329-39. Epub 2005 Oct 25.PMID: 16249217 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    High prevalence of hepatitis B virus infection and inferior vena cava obstruction among patients with liver cirrhosis or hepatocellular carcinoma in Nepal.

    Shrestha SM, Shrestha S, Shrestha A, Tsuda F, Endo K, Takahashi M, Okamoto H.

    J Gastroenterol Hepatol. 2007 Nov;22(11):1921-8.PMID: 17914971 [PubMed - indexed for MEDLINE]Related articles

    8.

    Management of patients with decompensated HBV cirrhosis.

    Fontana RJ.

    Semin Liver Dis. 2003 Feb;23(1):89-100. Review.PMID: 12616454 [PubMed - indexed for MEDLINE]Related articles

    9.

    Quiet reflection after effective action: hepatitis B viraemia and hepatocellular carcinoma recurrence.

    Abdo AA, Sanai FM.

    Liver Int. 2008 Apr;28(4):423-5. No abstract available. PMID: 18339067 [PubMed - indexed for MEDLINE]Related articles

    10.

    [Therapeutic approach to chronic hepatitis B and C in the dawn of the third millenium]

    Adler M, Bourgeois N.

    Rev Med Brux. 2001 Jun;22(3):141-51. Review. French. PMID: 11488081 [PubMed - indexed for MEDLINE]Related articles

    11.

    [Treatment of hepatitis B and C -- current standards]

    Zeuzem S.

    Dtsch Med Wochenschr. 2004 Sep 3;129 Suppl 2:S57-9. German. No abstract available. PMID: 15368169 [PubMed - indexed for MEDLINE]Related articles

    12.

    Hepatitis B.

    Lin KW, Kirchner JT.

    Am Fam Physician. 2004 Jan 1;69(1):75-82. Review. Erratum in: Am Fam Physician. 2004 Apr 15;69(8):1863. PMID: 14727820 [PubMed - indexed for MEDLINE]Related articles

    13.

    Summaries for patients. Does exposure to hepatitis B virus increase the risk for liver cancer in patients with hepatitis C infection?

    [No authors listed]

    Ann Intern Med. 2007 May 1;146(9):I59. No abstract available. PMID: 17470828 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis.

    Mazzella G, Accogli E, Sottili S, Festi D, Orsini M, Salzetta A, Novelli V, Cipolla A, Fabbri C, Pezzoli A, Roda E.

    J Hepatol. 1996 Feb;24(2):141-7.PMID: 8907566 [PubMed - indexed for MEDLINE]Related articles

    15.

    Does interferon therapy for chronic hepatitis B reduce the risks of developing cirrhosis and hepatocellular carcinoma?

    Lok AS.

    Hepatology. 1995 Oct;22(4 Pt 1):1336-8. No abstract available. PMID: 7557891 [PubMed - indexed for MEDLINE]Related articles

    16.

    Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers.

    Yu MW, Hsu FC, Sheen IS, Chu CM, Lin DY, Chen CJ, Liaw YF.

    Am J Epidemiol. 1997 Jun 1;145(11):1039-47.PMID: 9169913 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    [Treatments for hepatitis virus C infections]

    Pol S, Fontaine H, Vallet-Pichard A.

    Gastroenterol Clin Biol. 2001 Mar;25(3):287-307. Review. French. No abstract available. PMID: 11395676 [PubMed - indexed for MEDLINE]Related articles

    18.

    Natural history of chronic hepatitis B - clinical implications.

    McMahon BJ.

    Medscape J Med. 2008 Apr 16;10(4):91. Review. No abstract available. PMID: 18504503 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Antibody to hepatitis B core antigen and risk for hepatitis C-related hepatocellular carcinoma: a prospective study.

    Ikeda K, Marusawa H, Osaki Y, Nakamura T, Kitajima N, Yamashita Y, Kudo M, Sato T, Chiba T.

    Ann Intern Med. 2007 May 1;146(9):649-56.PMID: 17470833 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    [Hepatitis B--a viral oncogene?]

    Weis NM, Krogsgaard K.

    Ugeskr Laeger. 2002 Dec 9;164(50):5940-4. Review. Danish. PMID: 12553116 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data